Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma. - Shinozaki T; Togasaki K; Hamamoto J; Mitsuishi A; Fukushima T; Sugihara K; Ebisudani T; Okada M; Saito A; Shigematsu L; Takaoka H; Ito F; et al. (Nature communications, 2025)